- In June 2024, BIOMÉRIEUX received FDA approval for its BIOFIRE SPOTFIRE Respiratory/Sore Throat, a point-of-care (POC) platform
- In May 2024, Cipla entered into an agreement to invest in Achira Labs Private Limited, a company responsible for the commercialization of point-of-care test kits in India
- In May 2023, bioMérieux obtained the US FDA CLIA-waiver for the BIOFIRE SPOTFIRE Respiratory (R) Panel Mini, a multiplex PCR-based test approved for use on the BIOFIRE SPOTFIRE System
- In August 2023, BD received US FDA approval for its BD Respiratory Viral Panel (RVP) for the BD MAX System, a molecular diagnostic test that identifies and distinguishes SARS-CoV-2, influenza A, influenza B, and Respiratory Syncytial Virus (RSV) in approximately 2 hours
- In March 2023, bioLytical Laboratories Inc. received Health Canada approval for its INSTI Multiplex HIV-1/2 Syphilis Antibody Test
- In December 2023, Thermo Fisher Scientific Inc. partnered with Project HOPE, a leading global health organization, to expand the accessibility of HIV diagnostic services for HIV-positive youth in Sub-Saharan Africa
Frequently Asked Questions
The market is segmented based on Global Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Segmentation, By Test Type (Clinical Chemistry and Immunodiagnostics), Application (Infectious Diseases, Oncology, Endocrinology, Autoimmune Disorders, Basic Metabolite Panel, Liver Function Test, Electrolyte Panel, Kidney Function Test, Lipid Profile, Specialty Chemical Test, Thyroid Profile, and Others), End User (Hospitals, Clinical Laboratories, Diagnostic Centers, Academic and Research Institutes, and Others) – Industry Trends and Forecast to 2032
.
The Global Point Of Care Poc Clinical Chemistry And Immunodiagnostic Market size was valued at USD 11.88 USD Billion in 2024.
The Global Point Of Care Poc Clinical Chemistry And Immunodiagnostic Market is projected to grow at a CAGR of 4.16% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
